Mark H Eckman

Author PubWeight™ 51.20‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012 5.29
2 Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012 5.27
3 The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med 2004 3.63
4 Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012 3.14
5 Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers. Arch Intern Med 2009 2.08
6 Provisional vs. complex stenting strategy for coronary bifurcation lesions: meta-analysis of randomized trials. J Invasive Cardiol 2009 2.03
7 Outcomes of hemodialysis patients in a long-term care hospital setting: a single-center study. Am J Kidney Dis 2009 1.68
8 Statin use following intracerebral hemorrhage: a decision analysis. Arch Neurol 2011 1.59
9 Underuse of controller medications among children with persistent asthma in the Ohio medicaid population: evolving differences with new medications. Ambul Pediatr 2005 1.53
10 Early versus delayed bilateral subthalamic deep brain stimulation for parkinson's disease: a decision analysis. Mov Disord 2010 1.48
11 Cost-effectiveness of latent tuberculosis screening before steroid therapy for idiopathic nephrotic syndrome in children. Am J Kidney Dis 2012 1.40
12 Impact of bariatric surgery on life expectancy in severely obese patients with diabetes: a decision analysis. Ann Surg 2015 1.08
13 Oral cyclophosphamide for active scleroderma lung disease: a decision analysis. Med Decis Making 2008 1.01
14 Application of a decision support tool for anticoagulation in patients with non-valvular atrial fibrillation. J Gen Intern Med 2008 1.01
15 Psychosocial risk factors for adverse outcomes in patients with nonvalvular atrial fibrillation receiving warfarin. J Gen Intern Med 2005 0.99
16 Predictors of warfarin use among Ohio medicaid patients with new-onset nonvalvular atrial fibrillation. Arch Intern Med 2003 0.98
17 Health values of adolescents with cystic fibrosis. J Pediatr 2003 0.95
18 Subthalamic nucleus-deep brain stimulation for early motor complications in Parkinson's disease-the EARLYSTIM trial: early is not always better. Mov Disord 2014 0.94
19 Cost-effectiveness analysis of ED decision making in patients with non-high-risk heart failure. Am J Emerg Med 2009 0.94
20 Decision modeling to estimate the impact of gastric bypass surgery on life expectancy for the treatment of morbid obesity. Arch Surg 2010 0.90
21 Understanding preferences for disclosure of individual biomarker results among participants in a longitudinal birth cohort. J Med Ethics 2010 0.88
22 Thiopurine S- methyltransferase [corrected] testing in idiopathic pulmonary fibrosis: a pharmacogenetic cost-effectiveness analysis. Lung 2010 0.87
23 The potential of shared decision making to reduce health disparities. J Law Med Ethics 2011 0.86
24 Cost-effectiveness of total pancreatectomy and islet cell autotransplantation for the treatment of minimal change chronic pancreatitis. J Gastrointest Surg 2014 0.84
25 Racial disparities in the filling of warfarin prescriptions for nonvalvular atrial fibrillation. Am J Med Sci 2007 0.84
26 Valuation of scleroderma and psoriatic arthritis health states by the general public. Health Qual Life Outcomes 2010 0.82
27 Evaluating patient values and preferences for thromboprophylaxis decision making during pregnancy: a study protocol. BMC Pregnancy Childbirth 2012 0.82
28 The impact of expected HIV transmission rates on the effectiveness and cost of ruling out HIV infection in infants. Med Decis Making 2002 0.80
29 Cost-effectiveness of intravenous acetaminophen for pediatric tonsillectomy. Paediatr Anaesth 2014 0.79
30 The use of z scores in probabilistic sensitivity analyses. Med Decis Making 2014 0.78
31 Radioiodine or surgery for toxic thyroid adenoma: dissecting an important decision. A cost-effectiveness analysis. Thyroid 2004 0.78
32 Cost-effectiveness of telemetry for hospitalized patients with low-risk chest pain. Acad Emerg Med 2011 0.78
33 Use of regression modeling to simulate patient-specific decision analysis for patients with nonvalvular atrial fibrillation. Med Decis Making 2003 0.77
34 A randomized study of scleroderma health state values: a picture is worth a thousand words, and quite a few utiles. [corrected]. Med Decis Making 2008 0.77
35 Cost-effectiveness of prophylactic low molecular weight heparin in pregnant women with a prior history of venous thromboembolism. Am J Med 2005 0.77
36 Presidential reflections on the 25th anniversary of the society for medical decision making. Med Decis Making 2004 0.76
37 Cost effectiveness of recombinant factor VIIa for treatment of intracerebral hemorrhage. BMC Neurol 2008 0.75
38 Response. Chest 2013 0.75
39 Usability of an atrial fibrillation anticoagulation decision-support tool. J Prim Care Community Health 2011 0.75
40 Patient-specific decision modeling to guide the use of drotrecogin alpha (activated) in patients with severe sepsis. J Crit Care 2008 0.75
41 Women's values and preferences and health state valuations for thromboprophylaxis during pregnancy: A cross-sectional interview. Thromb Res 2016 0.75
42 How Much Should We Pay to Minimize Pancreatic Leak? The Cost-effectiveness of Pasireotide in Pancreatic Resection: RETRACTED. Ann Surg 2016 0.75
43 Cost-effectiveness of cervical spine clearance interventions with litigation and long-term-care implications in obtunded adult patients following blunt injury. J Trauma Acute Care Surg 2016 0.75